Insider Transactions in Q1 2022 at Liberty Latin America Ltd. (LILA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
15,667
-7.5%
|
$141,003
$9.59 P/Share
|
|
Mar 31
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
37,705
+15.29%
|
-
|
|
Mar 31
2022
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,904
+0.1%
|
$17,136
$9.59 P/Share
|
|
Mar 31
2022
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
952
+0.15%
|
$8,568
$9.7 P/Share
|
|
Mar 31
2022
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,904
+3.63%
|
$17,136
$9.59 P/Share
|
|
Mar 31
2022
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
952
+4.3%
|
$8,568
$9.7 P/Share
|
|
Mar 31
2022
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,904
+4.16%
|
$17,136
$9.59 P/Share
|
|
Mar 31
2022
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
952
+4.99%
|
$8,568
$9.7 P/Share
|
|
Mar 31
2022
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
336
+0.11%
|
$3,024
$9.59 P/Share
|
|
Mar 31
2022
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+0.11%
|
$1,512
$9.7 P/Share
|
|
Mar 28
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
40,000
-47.35%
|
$360,000
$9.84 P/Share
|
|
Mar 15
2022
|
Miranda Curtis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,174
+18.78%
|
-
|
|
Mar 15
2022
|
Miranda Curtis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,587
+21.71%
|
-
|
|
Mar 15
2022
|
Daniel E. Sanchez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,587
+23.99%
|
-
|
|
Mar 15
2022
|
Daniel E. Sanchez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,793
+20.71%
|
-
|
|
Mar 15
2022
|
Eric Louis Zinterhofer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,174
+12.84%
|
-
|
|
Mar 15
2022
|
Eric Louis Zinterhofer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,587
+15.05%
|
-
|
|
Mar 15
2022
|
Brendan J Paddick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,174
+0.39%
|
-
|
|
Mar 15
2022
|
Brendan J Paddick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,587
+0.58%
|
-
|
|
Mar 15
2022
|
Alfonso De Angoitia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,076
+2.5%
|
-
|
|
Mar 15
2022
|
Alfonso De Angoitia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
538
+3.04%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
251,174
-8.58%
|
$2,260,566
$9.62 P/Share
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
205,801
+9.35%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
99,911
+8.35%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
176,840
+15.47%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
88,420
+16.04%
|
-
|
|
Mar 15
2022
|
Charles H R Bracken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,174
+13.72%
|
-
|
|
Mar 15
2022
|
Charles H R Bracken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,587
+17.28%
|
-
|
|
Mar 15
2022
|
Rocio Lorenzo CCO |
BUY
Grant, award, or other acquisition
|
Direct |
38,866
+50.0%
|
-
|
|
Mar 15
2022
|
Rocio Lorenzo CCO |
BUY
Grant, award, or other acquisition
|
Direct |
19,433
+50.0%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
25,765
-5.32%
|
$231,885
$9.62 P/Share
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
46,752
+11.97%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
15,628
-6.28%
|
$140,652
$9.68 P/Share
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
22,802
+11.61%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
38,866
+20.56%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
19,433
+20.09%
|
-
|
|
Mar 15
2022
|
Paul A Gould Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,076
+0.36%
|
-
|
|
Mar 15
2022
|
Paul A Gould Director |
BUY
Exercise of conversion of derivative security
|
Direct |
538
+0.37%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,939
-6.62%
|
$89,451
$9.62 P/Share
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
17,416
+13.57%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,747
-6.59%
|
$42,723
$9.68 P/Share
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,455
+13.72%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,926
+25.55%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,962
+26.39%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
36,091
-3.85%
|
$324,819
$9.62 P/Share
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
57,057
+8.11%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
19,524
-4.32%
|
$175,716
$9.68 P/Share
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
27,839
+8.23%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,526
+14.48%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,263
+14.9%
|
-
|